These lab-built alternatives weren't formulated with leisure use in mind. In the nineties, John W. Huffman and a staff of fellow chemists at Clemson College designed a few of the initial formulas for synthetic cannabinoid receptor agonists (SCRAs), a family members of substances that imitate the physiological and psychological impacts of cannabis o